Abstract
The pancreas is comprised of exocrine and endocrine compartments releasing digestive enzymes into the duodenum and regulating blood glucose levels by insulin and glucagon release. Tissue homeostasis is depending on transcription factor networks, involving Ptf1α, Ngn3, Nkx6.1, and Sox9, which are already activated during organogenesis. However, proper organ function is challenged by diets of high sugar and fat content, increasing the risk of type 2 diabetes and other disorders. A detailed understanding of processes that are important for homeostasis and are impaired during type 2 diabetes is lacking. Here, we show that Zeb1—a transcription factor known for its pivotal role in epithelial-mesenchymal transition, cell plasticity, and metastasis in cancer—is expressed at low levels in epithelial cells of the pancreas and is crucial for organogenesis and pancreas function. Loss of Zeb1 in these cells result in an increase of islet mass, impaired glucose tolerance, and sensitizes to develop liver and pancreas steatosis during diabetes and obesity. Interestingly, moderate overexpression of Zeb1 results in severe pancreas agenesis and lethality after birth, due to islet insufficiency and lack of acinar structures. We show that Zeb1 induction interferes with proper differentiation, cell survival, and proliferation during pancreas formation, due to deregulated expression of endocrine-specific transcription factors. In summary, our analysis suggests a novel role of Zeb1 for homeostasis in epithelial cells that is indispensable for pancreas morphogenesis and proper organ function involving a tight regulation of Zeb1 expression.
Similar content being viewed by others
Introduction
Proper pancreas organ function and homeostasis is highly challenged by the life style and diets of modern societies, leading to continuously raising disorders like type 2 diabetes, pancreatitis, and pancreatic cancer1,2,3,4. The pancreas is organized in an exocrine compartment, producing and releasing digestive enzymes into the intestine, and an endocrine compartment, i.e., the islets of Langerhans2. Endocrine cells regulate glucose concentrations in the blood by insulin and glucagon releasing β- and α-cells, respectively5,6. Although endocrine cells are very adaptable to different metabolic demands, the pancreas is vulnerable to continuous diets with high carbohydrates and fat content2. Consequently, type 2 diabetes is constantly rising, which is characterized by reduction of the insulin-producing β-cell mass, insulin production/secretion, loss of sensitivity to insulin, liver and pancreas steatosis and inflammation. To identify more efficient treatment options a more detailed understanding of pancreas organogenesis and function is needed.
During development the pancreas in mice is specified at E9.0 by budding from the ventral foregut endoderm into dorsal and ventral parts that eventually fuse at E12.51,5,6. Pdx1 expression is initiated in multiprogenitor cells that are specified by local repression of Shh, involving activin, retinoic acid, FGF, and BMP signals1,5,6. Pdx1, Ptf1α, and Sox9 are crucial for pancreas organogenesis and loss of any of these factors results in agenesis or hypoplasia7,8,9,10. During primary transition until E12.5 FGF10 signaling from the underlying mesoderm promotes Ptf1a and Sox9 expression to form tip (acini progenitors) and trunk cells (endocrine and duct progenitors)11,12,13. Ptf1α and Nkx6.1/Nkx6.2 specify tip and trunk cells, respectively, by repressing each other’s expression, orchestrated by the Notch pathway5,12,14,15,16. Secondary transition is initiated at E12.5 and lasts until E16.5, involving continued branching morphogenesis and specification of tip cells into acini by E15.5 and of endocrine progenitors by delamination of individual Ngn3+ cells from the monolayer epithelium of the trunk to form islets1,11,16,17,18,19. During the second transition Ptf1α, Pdx1 and Sox9 become restricted to acini, islets and ducts, respectively6.
Endocrine cell delamination requires activation of epithelial-mesenchymal transition (EMT)20, a program that is activated also during tumorigenesis by EMT transcription factors including Snail, Slug, and Zeb1/2. Zeb1 is well known for regulating tumorigenesis, metastasis, and therapy resistance21,22,23,24,25,26,27. Activation of Zeb1 induces a transient loss of epithelial characteristics and a gain of mesenchymal traits enabling cell motility and malignancy24,26,28. We recently identified that, although Zeb1 is almost undetectable in normal epithelia and tumor cells before EMT, an intact Zeb1 allele promotes initiation and progression of precancerous lesions of the pancreas (PanINs)22. During embryogenesis and in adult tissues, Zeb1 is mainly confined to neuronal and mesodermal lineages, whereas epithelia display only weak or no Zeb1 expression29,30. Zeb1 knockout embryos show severe skeletal defects, impaired neural tube closure, and die perinataly29,31. Zeb1 is involved in the cell-type specification, tissue function, and regeneration, including muscle, bone, and melanocyte differentiation32,33,34,35. However, not much is known about Zeb1 function in epithelia. Here, we analyzed the role of Zeb1 during pancreas formation and homeostasis using loss- and gain of function approaches in mice. We found that Zeb1 is involved in the maintenance of tissue homeostasis and protects the pancreas from accelerated tissue damage during metabolic disorders, like diabetes mellitus. Moreover, our data indicate that Zeb1 levels need to be tightly regulated to form and maintain a pancreas with appropriate acinar to islet ratios and to avoid tissue damage.
Results
Depletion of Zeb1 in the embryonic pancreas results in increased organ weight
We explored Zeb1 expression in non-mesenchymal cells by using the zygotic Zeb1 knockout29. Besides strong expression of Zeb1 in the brain, neural tube, and mesoderm-derived tissues, we detected weak expression in the pancreas epithelial compartment, which was lost in Zeb1 knockout embryos (Suppl. Fig. S1A). To specifically target Zeb1 in these cells we used conditional gene ablation by Pdx1-Cre29,36 starting from E8.5. Efficient, but not always uniform recombination was observed with the mTmG Cre-reporter allele (Suppl. Fig. S1B)37 and Pdx1-Cre mediated Zeb1 depletion (hereafter Zeb1Δ/Δpanc) was restricted to the pancreas epithelium, including acini, ducts, and islets (Suppl. Fig. S1B). No obvious malformation or atrophy was found upon Zeb1 loss (Fig. 1A). However, mutant mice displayed an increase in pancreas mass, albeit significant only at six months of age due to high individual variability (Fig. 1B, left). Such alterations were not observed in other organs (Fig. 1B, right). At six months heterozygous mice also showed a trending increase in pancreas mass (Fig. 1B). Tissue architecture and abundance of the exocrine compartment (acini and intralobular ducts) and endocrine islets of Langerhans were not affected (Fig. 1C). We detected an increase in proliferation by Ki67 and a reduced, but not yet significant, level of apoptosis by cleaved Caspase 3 immunohistochemistry in pancreata of Zeb1∆/∆panc animals. In adult pancreata epithelial-specific Zeb1 expression was confined to only individual acinar and islet cells, but was absent in Zeb1-deficient mice. Yet, no effect of Zeb1 depletion on protein expression of bona fide Zeb1 target genes, like E-cadherin (E-cad), was detected (Fig. 1D).
These results show that Zeb1 is expressed at low levels in pancreas epithelial lineages during development and in adult mice and that Zeb1 depletion results in increased organ weight likely supported by imbalanced proliferation and apoptosis rates.
Zeb1 deficiency affects normal function of the endocrine pancreas
Combined with an increase in organ mass Zeb1∆/∆panc mice showed elevated Insulin-positive islet β-cell areas (Fig. 2A). To address whether this increase in islet mass had also functional impact on blood glucose regulation we subjected Zeb1fl/fl and Zeb1Δ/∆panc littermates to an intraperitoneal glucose tolerance test (GTT)38. As expected, intraperitoneal (i.p.) injection of 2 g/kg body weight glucose raised blood glucose levels to ~150% in control mice (Fig. 2B, gray line), which declined to pre-injection levels within 120 min. In contrast, glucose levels increased up to 200% in Zeb1∆/∆panc littermates (Fig. 2B, red line) and remained higher than those of control mice until 60 min post glucose injection, indicating that acute endocrine function was impaired upon Zeb1 loss. Interestingly, Insulin concentrations also showed a higher, but still not significant peak in Zeb1∆/∆panc mice, whereas they trend to be slightly reduced before fasting and GTT (t = 0; Fig. 2C) as well as in untreated, non-fasting mice (Suppl. Fig. S2A). The low-affinity glucose transporter, Glut2 regulates membrane depolarization and Insulin granule fusion with the plasma membrane in β-cells; one key step in blood glucose level sensing39. In accordance with the increased area of islets we detected also a trend towards increased Glut2-positive areas in Zeb1∆/∆panc mice but no deregulation within individual cells or islets (Fig. 2A). Pancreas bulk mRNA analysis revealed no significant decrease in Zeb1 transcript levels and no changes in Zeb1-regulated targets, like E-cad (Cdh1) and Vimentin (Vim) (Fig. 2D), owing to the major contribution of Zeb1 expression in the pancreas by mesenchymal cells not targeted by Pdx1-Cre. A specific lineage marker for acinar cells, Amylase (Amy2), was unchanged, whereas the ductal marker and Notch target Hes1 was increased in Zeb1∆/∆panc pancreata. Although the endocrine lineage and differentiation transcription factor Pdx1 was not altered, two downstream transcription factors for β-cell differentiation, were either significantly upregulated (Ngn3) or tended to be reduced (Nkx6-1) in mutants (Fig. 2D).
In summary, our findings show that cell composition is shifted in the Zeb1Δ/Δpanc pancreata towards an increase of islet β-cell mass, combined with altered endocrine marker gene expression likely causing systemic impairment on sensing/processing of blood glucose levels.
Zeb1 depletion reveals metabolic changes in diabetic mice
To discriminate Zeb1 function between endocrine and exocrine compartments we challenged the pancreas by induction of type 2 diabetes40 and chronic pancreatitis (CP). Mice subjected to high-fat diet (HFD) for 19 weeks developed type 2 diabetes, dramatically gained body weight (Fig. 3A, Suppl. Fig. S2B), and displayed elevated blood glucose levels by the trend in comparison to normal diet (ND)-fed mice. Moreover, a two to eightfold but not yet significant increase in steady-state Insulin levels was detected (Fig. 3B, Suppl. Fig. S2C–E), suggesting insulin resistance. In general, males were more susceptible to gain body weight than females and individuals show varying consequential effects. Although no apparent differences in body weight, blood glucose, and insulin levels were observed between the genotypes, only Zeb1Δ/Δpanc animals showed a tendency of retaining high glucose levels after the short period of fasting prior to GTT (Suppl. Fig. S2D). Upon increasing baseline glucose levels (t = 0) HFD-fed diabetic Zeb1Δ/Δpanc mice displayed no change in the glucose peak at 15 min after glucose injection and the diabetes-dependent impairment of glucose clearance (Fig. 3C, Suppl. Fig. S2F). Importantly, HFD-fed Zeb1Δ/Δpanc mice exhibited increased liver weight (Fig. 3D, Suppl. Fig. S2G). Despite high variability, we consistently found higher fractions of them displaying lipid deposition in the pancreas (≥40%, three out of six vs. one out of six mice) and apparent liver steatosis (≥40%, three out of six vs. two out of six mice; Fig. 3E–G, Suppl. Fig. S2G, H). Of note, Zeb1Δ/Δpanc males showed trending increased liver steatosis, but decreased pancreas lipid content in comparison to their control littermates, whereas Zeb1Δ/Δpanc females showed inverted effects (Suppl. Fig. S2I).
To challenge the exocrine compartment in Zeb1Δ/Δpanc mice, we performed hydrodynamic gene delivery of a constitutive Il17a expression vector to induce pancreatitis41. CP was detected in Zeb1fl/fl and Zeb1Δ/Δpanc individuals 15 days post injection, accompanied by massive tissue damage, especially of acinar cells, infiltration of CD45+ hematopoietic cells, and fibrosis without major differences (Suppl. Fig. S3).
In conclusion, Zeb1 deficiency mainly affects the endocrine compartment, leading to altered glucose and insulin levels that result in systemic effects by exacerbating disease pathology of type 2 diabetes including accelerated liver steatosis.
Moderate induction of Zeb1 in the pancreas causes agenesis
Zeb1 deletion in the pancreas affects pancreas homeostasis. To experimentally increase Zeb1 levels we made use of the indZeb1 knock-in allele (R26-Zeb1tg), harboring Zeb1-HA cDNA driven by the Rosa26 locus42 activated by Pdx1-Cre in indZeb1 mice (Fig. 4A). To our surprise, these mice died shortly after birth showing severe growth retardation with only a few individuals reaching 2–7 weeks of age (Fig. 4B, C), due to pancreas agenesis to variable extend and sporadic cyst formation. This observation was combined with more severe reduction of the islet mass (Fig. 4C). To discriminate whether moderate elevation of Zeb1 expression impaired pancreas specification or affected cell survival later, we analyzed E15.5 embryos, when the secondary transition was almost completed in control embryos. Although the size of the embryonic pancreas was slightly reduced, all indZeb1 embryos displayed a clearly discernible pancreas with proper gross morphology but included sporadic cystic or blood-filled structures (Fig. 4D). Zeb1 overexpression was confirmed by immunofluorescence staining, showing expression at the detection limit, with a few patches of more robust expression (Fig. 4E and inset). We observed a slight global reduction in the expression of the Zeb1 target E-cad with almost negative patches of higher Zeb1 levels in mutant embryos (Fig. 4D). mRNA analysis of pancreata from embryos and pups confirmed a moderate 1.5 and 3-fold increase in Zeb1 transcripts resulting in lower Cdh1 and higher Vim levels in indZeb1, whereas Zeb1 depletion had no robust effect (Fig. 4F).
In summary, we established mice with an approximately twofold ectopic Zeb1 expression in pancreas epithelial cells that is incompatible with proper pancreas organogenesis resulting in agenesis at birth.
Proper pancreas morphogenesis in indZeb1 mice is impaired during secondary transition
To identify how pancreas formation is compromised by elevated Zeb1, we analyzed key developmental stages after completion of the primary transition (E13.5), during (E15.5), and after the secondary transition (E17.5) on a cellular level in indZeb1 and Zeb1Δ/Δpanc embryos. Histological analysis confirmed that the size of the pancreas of indZeb1 was affected mainly during the secondary transition at E15.5 and E17.5 to a varying extend (Fig. 5A). No apparent defects were observed in Zeb1Δ/Δpanc pancreata throughout organogenesis (Fig. 5A). In Zeb1-proficient control (ctrl) and Zeb1fl/fl littermates at E13.5 cellular differentiation into tip and trunk cells was identified by HE staining (Fig. 5A, top panel). In contrast, this proper morphological separation was not present in indZeb1 specimens. Here, we observed more undifferentiated clusters of cells that became more prominent at E15.5 and acinar morphogenesis was only initiated in some areas of the pancreas (Fig. 5A, middle panel). Moreover, separation into individual lobes that were present at E15.5 in ctrl and Zeb1fl/fl embryos was clearly lacking in indZeb1 individuals. These developmental defects were more pronounced at E17.5, when the pancreas was smaller in indZeb1 embryos (Fig. 5A, lower panel, arrowheads), although proper acinar and duct structures were found in less affected areas. Reduction in organ size was reflected by a trend to decreased proliferation and increased apoptosis (Fig. 5B–D), whereas it was unchanged in Zeb1Δ/Δpanc embryos.
Our findings indicate that ectopic Zeb1 expression is interfering with secondary transition and blocks proper lineage specification leading to an accumulation of undifferentiated cells combined with indications of impaired proliferation and increased apoptotic rates.
Elevated Zeb1 expression in the embryonic pancreas interferes with proper endocrine differentiation
Next, we checked for lineage marker gene expression, i.e., Ptf1α for tip/acinar cells, Sox9 for trunk/duct cells, and Pdx1 and Glucagon for endocrine/α-cells. At E13.5 we found uniform expression of Ptf1α with a preference to acinar/tip structures and Sox9 labeled trunk/duct/endocrine progenitors in ctrl embryos (Fig. 6A, top panel). indZeb1 embryos also displayed Ptf1α expression, but slightly weaker, whereas Sox9 was less confined, indicating that lineage segregation was delayed or inhibited upon Zeb1 induction (Fig. 6A, bottom panel). At the end of the secondary transition at E15.5 Ptf1α properly decorated acinar structures, Pdx1 and Glucagon were found in more centrally located endocrine derivatives and Sox9 in ductal cells of ctrl embryos (Fig. 6B, top panel, Suppl. Fig. S4A). Upon Zeb1 overexpression acinar and duct cells were still identified by Ptf1α and Sox9, respectively (Fig. 5B, bottom panel, Suppl. Fig. S4A). However, we noticed a substantial reduction of Pdx1 and Glucagon positive cells, indicating a reduction of the endocrine lineage. This was most apparent in patches of higher ectopic Zeb1 levels, in which also E-cad was reduced, but without altering Ptf1α and Sox9 expression (Fig. 6B, Suppl. Fig. S4A). Areas with milder defects displayed proper tissue architecture with proper marker gene expression (Fig. 6C, Suppl. Fig. S4B). Nkx6.1 is a key transcription factor for lineage specification in multiprogenitor cells in early stages and for islet β-cell formation later during organogenesis43. In E13.5 ctrl pancreata Nkx6.1 labeled distinct epithelial trunk and tip cell clusters and was continuously expressed until E15.5 (Fig. 6D). In contrast, indZeb1 embryos showed uniform expression of Nkx6.1 in more undifferentiated cell clusters at E13.5 and E15.5 (Fig. 6D). At E17.5 the number of Nkx6.1-positive cells was largely reduced in indZeb1 compared to ctrl littermates (Fig. 6D).
This analysis demonstrates that pancreas cell differentiation and morphogenesis are sabotaged by moderate Zeb1 overexpression, mainly affecting the endocrine lineage.
Zeb1 induction reduces expression of miR-200 family members that are regulators of β-cell function
We analyzed transcript levels of marker genes in the pancreas of indZeb1 and Zeb1Δ/Δpanc embryos and pups. Ductal marker gene expression (Hes1) was almost unchanged in all embryonic stages and genotypes. Amy2 (acini-specific) was initially increased, but reduced in indZeb1 mutants between E15.5 and E17.5 (Fig. 7A, left). Substantial changes were observed in markers of endocrine cells of indZeb1 embryos/pups at all analyzed stages. Pdx1, Ngn3 (endocrine progenitors), Ins2, Gcg (β- and α-cells, respectively), and Glut2 (Slc2a2, β-cells) were consistently reduced to 10–50% of control levels, further supporting the finding of a decisive impact of Zeb1 overexpression on the endocrine lineage (Fig. 7A, left). Zeb1Δ/Δpanc pancreata showed a trending increase in the expression of the β- and α-cell marker genes Ins2 and Gcg at E17.5 and P2 concomitant to decrease in expression of Slc2a2 at E15.5 and P2 (Fig. 7A, right). This finding was in agreement with an increase in islet mass in Zeb1Δ/Δpanc adult mice.
miRNAs play a crucial role in pancreas organogenesis and homeostasis44. In particular, the miR-200 family is important and forms a double-negative feedback loop with Zeb1. High miR-200 levels downregulate Zeb1, whereas increased Zeb1 expression represses miR-200s expression affecting cellular differentiation45,46. In the pancreas miR-200s are crucial for proper organ formation, but ectopic elevation results in islet β-cell apoptosis in type 2 diabetes mice whereas depletion protects against diabetic loss of β-cells47,48. In accordance with Zeb1-mediated repression of miR-200s we found constantly reduced expression of miR-429, miR-200a/c, and miR-141, as well as of miR-203 in indZeb1, which was most significant at E17.5 and P2 (Fig. 7B, left). Apparently, miR-200 repression did not prevent islet and β-cell loss, indicating additional dominating effects of a Zeb1 increase. Acinar and islet-specific loss of Zeb1 did not induce detectable alterations in miRNA levels (Fig. 7B, right). However, in adult Zeb1Δ/Δpanc mice, when islet mass was increased, we observed a slight elevation of miR-200s, reaching significance only for miR-200a (Suppl. Fig. S5).
These results confirm that manipulation of Zeb1 expression mainly affects cells of the endocrine lineage and altered endocrine marker gene expression likely represents a shift in cell composition of the different lineages. Activation and loss of Zeb1 affects Zeb1-targeted miRNAs, but alterations in miR-200s cannot fully account for the dramatic changes in pancreas morphogenesis and function when Zeb1 is artificially increased or depleted.
Discussion
Tissue integrity and organ function of the pancreas is dependent on a large variety of signaling cues, transcription factors and metabolic crosstalk. A delicate equilibrium of constant glucose levels in the blood is necessary for homeostasis. This is regulated by ancient mechanisms to cope with periods of poor and exuberant nutrition and physical activity. Constant excess nutrition promotes hyperglycemia, obesity, and type 2 diabetes1,2. Transcription factor networks orchestrated by Pdx1, Ptf1α, Sox9, Hnf1α, Gata4/6, Ngn3 are indispensable for morphogenesis and homeostasis of the pancreas and loss of any of these result in a moribund phenotype caused by hypoplasia of islets1,5,6,12,49. Our analyses demonstrated that pancreas organogenesis and function is also dependent on Zeb1, a transcription factor mainly confined to non-epithelial cells and a potent inducer of EMT. We found that Zeb1 is expressed at low levels in the pancreas primordium and in acinar and islet cells. Inactivation of Zeb1 increases islet mass, levels of glucose and Insulin and promotes liver steatosis. In contrast, a ~2-fold elevated Zeb1 expression during embryogenesis blocks proper differentiation and cell survival of acinar and islet progenitors during the second transition leading to pancreas agenesis and postnatal lethality. We show that Zeb1 expression needs to be tightly regulated for proper pancreas morphogenesis and organ function.
During development EMT-TFs are important to drive key morphogenetic events26,28. While Snail induces EMT during gastrulation, Zeb1 is needed for mesoderm-derived differentiation processes at later stages, e.g., of bone, muscle, and melanocytes23,31,32,33,34. The function of EMT-TFs in normal epithelia might have been largely overlooked due to their very prominent expression in mesoderm and neurectoderm-derived cell types. In the intestine Snail regulates differentiation and homeostasis, since epithelial Snai1 depletion and overexpression result in apoptotic loss and increase of crypt base columnar cells, respectively50. Slug regulates stem/progenitor cells and luminal differentiation in the epithelium during mammary gland morphogenesis51. We add another level of EMT-TF function in epithelia with a novel role of Zeb1 in the pancreas that requires tight regulation of expression. Of note, other EMT-TFs are also involved in pancreas formation. Ngn3 increases Snai1 and Snai2 (Slug) expression post-transcriptionally in duct cells, which is crucial for efficient Cdh1 downregulation and delamination of Ngn3+ endocrine progenitors20,50,52. In our experiments, we did not detect a contribution of Zeb1 in this process. Although experimental Zeb1 activation resulted in decreased E-cad expression in the early pancreas, the reduction of all endocrine markers including Ngn3 rather suggests inhibition of endocrine specification by Zeb1. It implies that the role of Zeb1 in specification, differentiation, proliferation, and survival of progenitor cells is intricate and clearly differs from the functions of Snail and Slug. This is in agreement with the non-redundant functions of EMT-TFs in other contexts23.
Among several important miRNAs the miR-200 family is a powerful regulator of pancreas function44. Members of this family are upregulated during diabetes and drive β-cell apoptosis, whereas hyperglycemia and β-cell apoptosis can be inhibited by ablation of miR-200s47. In a rat cell culture model of β-cells (INS-1), knockdown of Zeb1 was sufficient to induce apoptosis by upregulated miR-200s48. In our in vivo analyses we observed a similar anti-correlated relationship leading to miR-200s downregulation when Zeb1 was experimentally increased. However, we neither observed a miR-200 mediated increase in apoptosis upon Zeb1 knockout nor reduced cell death upon Zeb1 overexpression, but rather opposite effects. This indicates that the role of Zeb1 and miRNAs in the pancreas is more complex, maybe stage-specific and different in acini and islets. Spatiotemporal differences in activities of the rat insulin47 and mouse Pdx1 promoters to drive gene deletion/activation may also contribute to opposing findings.
Why does a moderate overexpression of Zeb1 result in such a strong pancreas hypoplasia? Interestingly, Zeb1 overexpression during hematopoiesis or widespread Snai1 and Snai2 overexpression in mice that includes the pancreas did not show such dramatic effects42,50,53,54. In contrast to depletion of Pdx1, Ptf1a or Mnx1, which shows early defects in initial pancreatic bud formation or expansion7,9,10,55, we here observed no effect on bud formation but on specification of exocrine, endocrine, and duct lineages later due to impaired cell survival and proliferation resulting in hyperplasia. Although we observed major downregulation of endocrine-specific genes—an indication that endocrine cells are more severely affected— our phenotype is different from other loss- and gain-of function mutations. For example, Ngn3−/−, Neurod1−/−, Nkx2-2−/− and Nkx6-1−/− mice display reduced or absent endocrine lineages, β-cell differentiation, and/or reduction in islet size43,56,57,58, e.g., due to endocrine to acinar fate switch16. The fact that Zeb1 affects cell survival and proliferation of all pancreas lineages is in agreement with its capacity to completely reprogram cells during EMT in cancer, leading to ample changes in cellular properties including metabolism and cell architecture22,27. Consequently, these findings support the hypothesis that Zeb1 expression is required for specific functions, but needs to be tightly regulated and thus kept at a low level for proper organ function.
Interestingly, Zeb1 deficiency resulted in pronounced liver steatosis indicating systemic consequences of pancreas-specific Zeb1 depletion. How Zeb1 is integrated in the complex regulation of diabetes, sex steroids, fatty liver, increase of visceral fat and pancreas steatosis still remains obscure. Obesity, hyperglycemia, insulin resistance, and GTT correlate with liver steatosis59,60,61,62. Pancreas dysfunction during diabetes stimulates peripheral lipolysis, the release of free fatty acids, and deposition in the liver which also correlates with pancreas lipomatosis63,64,65,66. Moreover, insulin resistance is increasing the portal flux of fatty acids facilitating adipokine release by pancreas adipocytes, which fosters free fatty acids in the circulation and liver steatosis65,66. In line with this, our mice that show steatosis in the pancreas but not in the liver might display the priming of this vicious cycle, whereas the presence of a fatty liver in obese diabetic mice indicates a more progressed disease state. Despite the small sample size in our experiments, it is tempting to speculate that Zeb1 attenuates disease pathology by inhibiting pancreas lipid deposition and liver steatosis. To test this hypothesis a more detailed analysis is required.
In conclusion, our findings indicate that Zeb1 function in the pancreas is indispensable for proper morphogenesis and homeostasis requiring very tight locus control to maintain low Zeb1 expression levels.
Materials and methods
Mice
Animal husbandry and all experiments were performed according to the European Animal Welfare laws and guidelines. The protocols were approved by the committee on ethics of animal experiments of Bavaria, Germany (Regierung von Unterfranken, Würzburg; TS-18/14 and 55.2-DMS-2532-2-59). Power analysis was used to calculate the sample size required for animal experiments. Animals were kept on a 12:12 h light-dark cycle and provided with food and water ad libitum in the animal facility of the Friedrich-Alexander University of Erlangen-Nürnberg. The Pdx1-Cre transgene (Tg(Pdx1-cre)6Tuv), generation of the conditional Zeb1 knockout alleles, Zeb1fl (Zeb1tm1.1Mpst) and Zeb1del (Zeb1tm1.2Mpst) as well as the mTmG Cre reporter (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo) have been described previously29,36,37. Coding sequences of HA-tagged Zeb1 were inserted into the Rosa26 locus for Cre-mediated gene activation42. A detailed description of R26-Zeb1tg mice will be described elsewhere. All mice were kept on a C57BL/6N background. Mice were sacrificed at indicated timepoints and tissues were fixed in 4% paraformaldehyde (PFA)/PBS overnight and embedded into paraffin, fresh frozen in TissueTek OCT at −80 °C or subjected to RNA isolation.
Induction of type 2 diabetes and CP
For induction of type 2 diabetes (T2D) mice were switched from normal chow diet (ND) to HFD with 60 kJ % fat (Ssniff, Soest, Germany) directly after weaning for 19–20 weeks40. Mice under HFD and control ND were weighed and venous blood glucose levels measured at indicated time-points to assess T2D progression.
CP was induced by hydrodynamic gene delivery of an Il17a expression vector into the liver, using a mouse Albumin promoter/Afp enhancer sequence of pLIVE (Mirus, Madison, WI, USA) to drive mouse Il17a expression41.
GTT and measurement of blood glucose and insulin levels
For the intraperitoneal GTT mice were fasted for 4–6 h and injected intraperitoneally with 2 g/kg body weight glucose38,40. Venous blood samples were taken before and during GTT at indicated time-points and blood glucose concentrations were measured with a glucometer (VPD, Bled, Slovenia). For quantification of insulin levels, plasma was isolated from the supernatant after centrifugation of blood samples for 15 min at 2000 × g at 4 °C. Quantification was carried out by the Ultra Sensitive Mouse Insulin ELISA Kit (Crystal Chem, Zaandam, Netherlands) according to the manufacturer’s instructions.
Statistical analysis
Prism 8 (GraphPad, San Diego, CA, USA) was used for statistical analysis. Data are represented by means ± SEM of n biological replicates as indicated. One-way ANOVA with Tukey multiple comparisons test was used to analyze ratios of pancreas weight versus total body weight, for quantification of Insulin/Glut2-areas and for proliferation and apoptosis. Two-way ANOVA with Tukey multiple comparisons test or Student’s t-test was used for qRT-PCR data for Zeb1fl/fl, Zeb1+/Δpanc, and Zeb1Δ/Δpanc. qRT-PCR data between E13.5 and P2, proliferation and apoptosis, GTT, glucose and Insulin levels, liver weight and steatosis were analyzed by Student’s multiple t-test, corrected for multiple comparisons, and the Holm-Sidak method for correction. Survival of indZeb1 was tested for significance by a log-rank (Mantel-Cox) test. In all analyses two-tailed tests were performed. P-values of statistical significance are represented as: *p < 0.05, **p < 0.01, ***p < 0.001. The variance between the statistically compared groups are similar. No estimate of variation has been performed within each group of data prior to statistical analysis.
References
Lorberbaum, D. S., Docherty, F. M. & Sussel, L. Animal models of pancreas development, developmental disorders, and disease. Adv. Exp. Med. Biol. 1236, 65–85 (2020).
Atkinson, M. A., Campbell-Thompson, M., Kusmartseva, I. & Kaestner, K. H. Organisation of the human pancreas in health and in diabetes. Diabetologia 63, 1966–1973 (2020).
Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913–2921 (2014).
Peery, A. F. et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 143, 1179–1187.e1171-1173 (2012).
Pan, F. C. & Wright, C. Pancreas organogenesis: from bud to plexus to gland. Dev. Dyn. 240, 530–565 (2011).
Shih, H. P., Wang, A. & Sander, M. Pancreas organogenesis: from lineage determination to morphogenesis. Annu Rev. Cell Dev. Biol. 29, 81–105 (2013).
Offield, M. F. et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122, 983–995 (1996).
Seymour, P. A. et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc. Natl Acad. Sci. USA 104, 1865–1870 (2007).
Jonsson, J., Carlsson, L., Edlund, T. & Edlund, H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606–609 (1994).
Krapp, A. et al. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 12, 3752–3763 (1998).
Zhou, Q. et al. A multipotent progenitor domain guides pancreatic organogenesis. Dev. Cell 13, 103–114 (2007).
Dassaye, R., Naidoo, S. & Cerf, M. E. Transcription factor regulation of pancreatic organogenesis, differentiation and maturation. Islets 8, 13–34 (2016).
Seymour, P. A. et al. A Sox9/Fgf feed-forward loop maintains pancreatic organ identity. Development 139, 3363–3372 (2012).
Jensen, J. et al. Control of endodermal endocrine development by Hes-1. Nat. Genet 24, 36–44 (2000).
Apelqvist, A. et al. Notch signalling controls pancreatic cell differentiation. Nature 400, 877–881 (1999).
Schaffer, A. E., Freude, K. K., Nelson, S. B. & Sander, M. Nkx6 transcription factors and Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors. Dev. Cell 18, 1022–1029 (2010).
Magenheim, J. et al. Ngn3(+) endocrine progenitor cells control the fate and morphogenesis of pancreatic ductal epithelium. Dev. Biol. 359, 26–36 (2011).
Murtaugh, L. C., Stanger, B. Z., Kwan, K. M. & Melton, D. A. Notch signaling controls multiple steps of pancreatic differentiation. Proc. Natl Acad. Sci. USA 100, 14920–14925 (2003).
Gu, G., Dubauskaite, J. & Melton, D. A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129, 2447–2457 (2002).
Gouzi, M., Kim, Y. H., Katsumoto, K., Johansson, K. & Grapin-Botton, A. Neurogenin3 initiates stepwise delamination of differentiating endocrine cells during pancreas development. Dev. Dyn. 240, 589–604 (2011).
Preca, B. T. et al. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. Int. J. Cancer 137, 2566–2577 (2015).
Krebs, A. M. et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat. Cell Biol. 19, 518–529 (2017).
Stemmler, M. P., Eccles, R. L., Brabletz, S. & Brabletz, T. Non-redundant functions of EMT transcription factors. Nat. Cell Biol. 21, 102–112 (2019).
Lambert, A. W., Pattabiraman, D. R. & Weinberg, R. A. Emerging biological principles of metastasis. Cell 168, 670–691 (2017).
Meidhof, S. et al. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol. Med. 7, 831–847 (2015).
Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. Emt: 2016. Cell 166, 21–45 (2016).
Wellner, U. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11, 1487–1495 (2009).
Yang, J. et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 21, 341–352 (2020).
Brabletz, S. et al. Generation and characterization of mice for conditional inactivation of Zeb1. Genesis 55 (2017).
Miyoshi, T. et al. Complementary expression pattern of Zfhx1 genes Sip1 and deltaEF1 in the mouse embryo and their genetic interaction revealed by compound mutants. Dev. Dyn. 235, 1941–1952 (2006).
Takagi, T., Moribe, H., Kondoh, H. & Higashi, Y. DeltaEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages. Development 125, 21–31 (1998).
Siles, L., Ninfali, C., Cortés, M., Darling, D. S. & Postigo, A. ZEB1 protects skeletal muscle from damage and is required for its regeneration. Nat. Commun. 10, 1364 (2019).
Denecker, G. et al. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression. Cell Death Differ. 21, 1250–1261 (2014).
Siles, L. et al. ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression. Mol. Cell Biol. 33, 1368–1382 (2013).
Bellon, E., Luyten, F. P. & Tylzanowski, P. delta-EF1 is a negative regulator of Ihh in the developing growth plate. J. Cell Biol. 187, 685–699 (2009).
Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437–450 (2003).
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593–605 (2007).
McShane, L. M., Franklin, Z. J., O’Harte, F. P. & Irwin, N. Ablation of glucagon receptor signaling by peptide-based glucagon antagonists improves glucose tolerance in high fat fed mice. Peptides 60, 95–101 (2014).
Thorens, B. GLUT2, glucose sensing and glucose homeostasis. Diabetologia 58, 221–232 (2015).
Winzell, M. S. & Ahren, B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53(Suppl 3), S215–S219 (2004).
Leppkes, M. et al. Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitis. Nat. Commun. 7, 10973 (2016).
Goossens, S. et al. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms. Haematologica 104, 1608–1616 (2019).
Sander, M. et al. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127, 5533–5540 (2000).
LaPierre, M. P. & Stoffel, M. MicroRNAs as stress regulators in pancreatic beta cells and diabetes. Mol. Metab. 6, 1010–1023 (2017).
Burk, U. et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582–589 (2008).
Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593–601 (2008).
Belgardt, B. F. et al. The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes. Nat. Med. 21, 619–627 (2015).
Filios, S. R. et al. MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis. J. Biol. Chem. 289, 36275–36283 (2014).
Jennings, R. E., Scharfmann, R. & Staels, W. Transcription factors that shape the mammalian pancreas. Diabetologia 63, 1974–1980 (2020).
Horvay, K. et al. Snai1 regulates cell lineage allocation and stem cell maintenance in the mouse intestinal epithelium. EMBO J. 34, 1319–1335 (2015).
Nassour, M. et al. Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis. PLoS ONE 7, e53498 (2012).
Rukstalis, J. M. & Habener, J. F. Snail2, a mediator of epithelial-mesenchymal transitions, expressed in progenitor cells of the developing endocrine pancreas. Gene Expr. Patterns 7, 471–479 (2007).
Perez-Mancera, P. A. et al. SLUG in cancer development. Oncogene 24, 3073–3082 (2005).
Shields, M. A. et al. Snail cooperates with KrasG12D to promote pancreatic fibrosis. Mol. Cancer Res. 11, 1078–1087 (2013).
Harrison, K. A., Thaler, J., Pfaff, S. L., Gu, H. & Kehrl, J. H. Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice. Nat. Genet 23, 71–75 (1999).
Gradwohl, G., Dierich, A., LeMeur, M. & Guillemot, F. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl Acad. Sci. USA 97, 1607–1611 (2000).
Naya, F. J. et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 11, 2323–2334 (1997).
Sussel, L. et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 125, 2213–2221 (1998).
Macotela, Y., Boucher, J., Tran, T. T. & Kahn, C. R. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 58, 803–812 (2009).
Carotti, S. et al. An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase. Am. J. Physiol. Gastrointest. Liver Physiol. 319, G469–G480 (2020).
Roden, M. Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat. Clin. Pr. Endocrinol. Metab. 2, 335–348 (2006).
Clark, J. M. & Diehl, A. M. Hepatic steatosis and type 2 diabetes mellitus. Curr. Diabetes. Rep. 2, 210–215 (2002).
Pezzilli, R. & Calculli, L. Pancreatic steatosis: Is it related to either obesity or diabetes mellitus? World J. Diabetes 5, 415–419 (2014).
Dite, P., Blaho, M., Bojkova, M., Jabandziev, P. & Kunovsky, L. Nonalcoholic fatty pancreas disease: clinical consequences. Digestive Dis. 38(suppl 2), 143–149 (2020).
van Geenen, E. J. et al. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 39, 1185–1190 (2010).
Gerst, F. et al. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion. Diabetologia 60, 2240–2251 (2017).
Acknowledgements
We thank Britta Schlund, Eva Bauer, Friederike Gräbner and Stefanie Gößwein for excellent technical assistance. This work was supported by the German Research Foundation (SFB850 TP A4 and B2, TRR305 TP A03, A04, B01 and B07, FOR2438 TP 04 and BR1399/9-1, BR1399/10-1, BR4145/1-1 and BR4145/2-1) and the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 861196 (PRECODE).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by I. Amelio
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lasierra Losada, M., Pauler, M., Vandamme, N. et al. Pancreas morphogenesis and homeostasis depends on tightly regulated Zeb1 levels in epithelial cells. Cell Death Discov. 7, 138 (2021). https://doi.org/10.1038/s41420-021-00522-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41420-021-00522-z